Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-2017 pediatric partial-onset seizures safety, efficacy, and pharmacokinetics study
jRCT2071260025Recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cenobamate in epilepsy and Focal Onset Epilepsy, sponsored by Ono Pharmaceutical. Primary endpoint: Adverse events and adverse drug reaction. Started Jun 2026; status: recruiting.
02
Drugs
cenobamate
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on jRCT2071260025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071260025.